lobbying_filings_raw: b2b6db64-e2a6-4c39-93ff-c5f016c40a59
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| b2b6db64-e2a6-4c39-93ff-c5f016c40a59 | Q1 | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 103667 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2011 | first_quarter | 2011-04-19T12:46:14.373000-04:00 | 250000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/b2b6db64-e2a6-4c39-93ff-c5f016c40a59/", "filing_uuid": "b2b6db64-e2a6-4c39-93ff-c5f016c40a59", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2011, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/b2b6db64-e2a6-4c39-93ff-c5f016c40a59/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "250000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Brian M. Meyer, Director, Government Affairs Division", "dt_posted": "2011-04-19T12:46:14.373000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "7272 WISCONSIN AVENUE", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "BETHESDA", "registrant_state": "MD", "registrant_zip": "20814", "registrant": {"id": 3457, "url": "https://lda.senate.gov/api/v1/registrants/3457/", "house_registrant_id": 31550, "name": "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", "description": null, "address_1": "4500 East West Highway", "address_2": "Suite 900", "address_3": null, "address_4": null, "city": "BETHESDA", "state": "MD", "state_display": "Maryland", "zip": "20814", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "THOMAS KRAUS", "contact_telephone": "+1 301-664-8692", "dt_updated": "2026-01-29T16:06:13.621912-05:00"}, "client": {"id": 103667, "url": "https://lda.senate.gov/api/v1/clients/103667/", "client_id": 12, "name": "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "MD", "state_display": "Maryland", "country": "US", "country_display": "United States of America", "ppb_state": "MD", "ppb_state_display": "Maryland", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-13"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "S. 296, Preserving Access to Life-Saving Medications Act, all provisions. Contacts concerning Food and Drug Admnistration (FDA)authority to manage drug shortages. Communication to Office of the National Coordinator for Health Information Technology regarding meaningful use implementation. Labor-Health and Human Services Appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (PL 111-148). Communication to repeal IRS form 1099 reporting provision in Affordable Care Act. S. 48, Pharmacist Student Loan Repayment Eligibility Act, all provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 44835, "prefix": "mr", "prefix_display": "MR.", "first_name": "BRIAN", "nickname": null, "middle_name": "M", "last_name": "MEYER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 44846, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "M", "last_name": "HILL", "suffix": "iii", "suffix_display": "III"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 54666, "prefix": "mr", "prefix_display": "MR.", "first_name": "CHRISTOPHER", "nickname": null, "middle_name": "J", "last_name": "TOPOLESKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}, {"lobbyist": {"id": 53735, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "NOONAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. Communication with CMS regarding Accountable Care Organizations and the Shared Savings Program, Value Based Purchasing Program, and Innovation Center. S. 274, Medication Therapy Management Empowerment Act, all provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 44835, "prefix": "mr", "prefix_display": "MR.", "first_name": "BRIAN", "nickname": null, "middle_name": "M", "last_name": "MEYER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 44846, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "M", "last_name": "HILL", "suffix": "iii", "suffix_display": "III"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 54666, "prefix": "mr", "prefix_display": "MR.", "first_name": "CHRISTOPHER", "nickname": null, "middle_name": "J", "last_name": "TOPOLESKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}, {"lobbyist": {"id": 53735, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "NOONAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Communication to Surgeon General on recognition of pharmacists as health care providers.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 44835, "prefix": "mr", "prefix_display": "MR.", "first_name": "BRIAN", "nickname": null, "middle_name": "M", "last_name": "MEYER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 44846, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "M", "last_name": "HILL", "suffix": "iii", "suffix_display": "III"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 54666, "prefix": "mr", "prefix_display": "MR.", "first_name": "CHRISTOPHER", "nickname": null, "middle_name": "J", "last_name": "TOPOLESKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}, {"lobbyist": {"id": 53735, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "NOONAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |